Seeking Alpha

China investigating Sanofi for alleged bribery - report

  • China is reportedly investigating Sanofi (SNY) for allegedly paying bribes of 1.7M yuan ($277,600) to over 500 Chinese doctors in order to increase sales.
  • The probe follows a report on Thursday in which a whistleblower accused the French pharmaceuticals company of making the payments.
  • The inquiry also comes as authorities investigate GSK for bribery and amid visits to other foreign drug companies, including Novo Nordisk, AstraZeneca and Eli Lilly.
From other sites
Comments (4)
  • The Long Tail of Finance
    , contributor
    Comments (891) | Send Message
     
    With China, isn't it usually the other way around?
    11 Aug 2013, 04:21 PM Reply Like
  • cn_habs
    , contributor
    Comments (342) | Send Message
     
    Most multinationals esp. those pharmaceuticals hand out bribes in China period. Whoever believes otherwise must think the world is black and white..
    11 Aug 2013, 11:35 PM Reply Like
  • User 353732
    , contributor
    Comments (5011) | Send Message
     
    Bribes are both demanded and accepted in China as a routine.
    This "investigation" is just more extortion.
    Bribes are to China what "political contributions" are to the US
    12 Aug 2013, 06:11 AM Reply Like
  • The Geoffster
    , contributor
    Comments (4131) | Send Message
     
    Opium Wars redux.
    12 Aug 2013, 10:27 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs